Trials Sponsors Conditions Drugs Pricing

Conditions

Neoplasm, Colorectal Neoplasm, Duodenal Neoplasm, Esophagus Neoplasm, Stomach

Outcome Measures

Primary Outcomes (1)

Rate of curative resection
through study completion, an average of 1 year

Secondary Outcomes (1)

Rate of R0 resection
through study completion, an average of 1 year

Other Outcomes (2)

Rate of perforation
30 days
Rate of delayed bleeding
30 days

Interventions

Endoscopic submucosal dissection (ESD)Procedure

Endoscopic injection of fluid into the gastrointestinal submucosal space followed by endoscopic knife dissection around and under the lesion so as to remove the lesion specimen in one piece with lesion free resection margins.

Also known as: ESD

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 100 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients diagnosed at or referred to Gastroenterology Clinic, University of Medicine and Pharmacy, "Agrippa Ionescu" Hospital, Bucharest, Romania

You may qualify if:

epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa

Sponsors & Collaborators

Carol Davila University of Medicine and Pharmacy
Otherlead

Study Sites (1)

"Agrippa Ionescu" Hospital

Bucharest, Romania

RECRUITING

Mihai L CiocirlanCONTACT0040722322625 mihai.ciocirlan@umfcd.ro

Biospecimen

Retention: SAMPLES WITHOUT DNA

Resected specimens of the gastrointestinal tract, fixed in formalin

MeSH Terms

Conditions

Stomach NeoplasmsColorectal NeoplasmsEsophageal NeoplasmsDuodenal Neoplasms

Interventions

Endoscopic Mucosal Resection

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesIntestinal NeoplasmsColonic Diseases

Study Officials

Mihai L Ciocirlan, Associate Professor
Carol Davila University of Medicine and Pharmacy
PRINCIPAL INVESTIGATOR

Central Study Contacts

Ciocirlan L Mihai, Associate Professor

CONTACT

0040722322625 mihai.ciocirlan@umfcd.ro

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 10 Years
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Clinical Professor (Associate Professor)

Study Record Dates

First Submitted

September 3, 2023

First Posted

September 13, 2023

Study Start

January 1, 2021

Actual (reported)

Primary Completion

January 2031

Estimated

Endoscopic Submucosal Dissection Registry

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Other Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Other Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Locations